Report Overview

Dry eye syndrome (DES), also known as keratoconjunctivitis sicca (KCS), is the condition of having dry eyes. Other associated symptoms include irritation, redness, discharge, and easily fatigued eyes. Blurred vision may also occur. The symptoms can range from mild and occasional to severe and continuous. Scarring of the cornea may occur in some cases without treatment.

In this report, we mainly study the drugs and eye drops for dry eye.

The global Dry Eye Syndrome revenue was US$ 5385 million in 2022 and is forecast to a readjusted size of US$ 7355.1 million by 2029 with a CAGR of 4.5% during the forecast period (2023-2029).

In India, the Dry Eye Syndrome revenue is expected to grow from US$ million in 2022 to US$ million by 2029, at a CAGR of % during the forecast period (2023-2029).

Global Dry Eye Syndrome key players include Allergan, Alcon, Novartis, Santen Pharma, Johnson & Johnson, etc. Global top five manufacturers hold a share over 60%.

North America is the largest market, with a share over 55%, followed by Europe and Asia-Pacific, both have a share over 35 percent.

In terms of product, Anti-inflammatory Drugs is the largest segment, with a share over 50%. And in terms of application, the largest application is Hospital, followed by Retail Pharmacy.

This report focuses on global and India Dry Eye Syndrome market, also covers the segmentation data of other regions in regional level and county level.

India is now the world’s most populous country. According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment. First and foremost, the key factor in India's rapid economic growth is the huge supply and demand from a large population base. Demand and supply sides working in both directions to support India's economic stability.

India is a market full of opportunities, and the demand for Dry Eye Syndrome will continue to grow rapidly in the future.

Global Dry Eye Syndrome Scope and Market Size

Dry Eye Syndrome market is segmented in regional and country, by players, by type and by distribution channel. Companies, stakeholders, and other participants in the global Dry Eye Syndrome market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by type and by distribution channel for the period 2018-2029.

For India market, this report focuses on the Dry Eye Syndrome market size by players, by Type and by Distribution Channel, for the period 2018-2029. The key players include the global and local players, which play important roles in India.

By Company

Allergan

Alcon

Novartis

Santen Pharma

Johnson & Johnson

Bausch & Lomb

Thea pharmaceuticals

URSAPHARM

SIMILASAN

Akorn

United Laboratories

Sun Pharmaceutical

Jianfeng Group

Segment by Type

Artificial Tears

Anti-inflammatory Drugs

Others

Segment by Distribution Channel

Hospital

Retail Pharmacy

Others

By Region

Americas

United States

Canada

Mexico

Brazil

China

APAC (excluding China)

Japan

South Korea

China Taiwan

ASEAN

India

EMEA

Europe

Middle East

Africa

Chapter Introduction

Chapter 1: Introduces Dry Eye Syndrome definition, global sales (volume and revenue), India market size, India percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Provides the analysis of various market segments by type, covering the volume, price, revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by distribution channel, covering the revenue, price, volume, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Detailed analysis of Dry Eye Syndrome companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Revenue and volume of Dry Eye Syndrome in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 6: Americas by type, by distribution channel and by country, sales, and revenue for each segment.

Chapter 7: EMEA by type, by distribution channel and by region, sales, and revenue for each segment.

Chapter 8: China by type, by distribution channel, sales, and revenue for each segment.

Chapter 9: APAC (excluding China) by type, by distribution channel and by region, sales, and revenue for each segment.

Chapter 10: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Dry Eye Syndrome sales, revenue, gross margin, and recent development, etc.

Chapter 11: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.

Chapter 12: Research findings and conclusion

Market Size Overview

USD Million

-

2026

-

2032

-

CAGR (2024-2032)

MARKET SIZE 2026

USD - MN

Million

MARKET SIZE 2032

USD - MN

Million

CAGR (2026-2032)

FASTEST GROWING REGION

Asia Pacific

LARGEST MARKET

Asia Pacific

Key Market Segmentation

By Purity Level

4N
5N
6N
Others

By Application

Semiconductor
Display
Solar
Others

By End-User Industry

Electronics
Optoelectronics
Photovoltaics
Others

By Region

North America
Europe
Asia Pacific
Latin America
Middle East & Africa

Regional Market Insights

Asia Pacific

China, Japan, South Korea, Southeast Asia, India

North America

U.S., Canada, Mexico

Europe

Germany, France, UK, Italy

South America

Brazil, etc.

Middle East and Africa

Turkey, GCC Countries, Africa, etc.

Global Perspective. Local Insight.

Our reports deliver comprehensive regional coverage to help you understand market dynamics, identify growth opportunities, and make informed decisions.

VALUE YOU CAN TRUST

Why Buy This Report?

Actionable insights. Trusted data. Smarter decisions.
Everything you need to stay ahead with confidence.

Gain a comprehensive understanding of the market

Make informed business decisions with data-backed insights

Identify growth opportunities and emerging markets

Stay ahead of competitors with actionable intelligence

Support strategic planning and investment decisions

Access detailed market segmentation and regional analysis

Benchmark key players, pricing, and market share

Benefit from reliable forecasts, trends, and future outlook

Understand customer demand, sales potential, and industry dynamics

Save research time with expert-validated data and analysis

Reliable Reports

Trusted by Leaders

Global Coverage

100+ Countries

24/7 Support

Secure Payments

Safe & Trusted